Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Davignon

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
The American Journal of Cardiology|June 27, 1986
Medical management of hyperlipidemia and the role of probucolJ Davignon
The Canadian Journal of Cardiology|June 17, 1998
Advances in drug treatment of dyslipidemia: focus on atorvastatinJ Davignon
International Journal of Clinical Practice. Supplement|July 23, 2005
Cardioprotective and other emerging effects of statinsJ Davignon
Progress in Clinical and Biological Research|January 1, 1979
Assessment of atherosclerosis for genetic analysis - emphasis on clinical expression or pathogenetic mechanism?J Davignon
L'Union Medicale Du Canada|December 1, 1976
[Plasma apolipoproteins]P Duclos, J Davignon
L'Union Medicale Du Canada|July 1, 1977
[Plasma apoproteins in dyslipoproteinemias. I. The hypolipidemias]P Duclos, J Davignon
L'Union Medicale Du Canada|July 1, 1978
[Plasma apolipoproteins in dyslipoproteinemias. III. LCAT deficiency and other hyperlipidemias]P Duclos, J Davignon
The American Journal of Cardiology|September 16, 1998
Current and future treatment of hyperlipidemia: the role of statinsM Farnier, J Davignon
L'Union Medicale Du Canada|November 1, 1971
[Combined electrophoresis and ultracentrifugation in diagnosis of primary hyperlipidemia]J Davignon, M Langelier
Current Opinion in Lipidology|February 19, 2000
Low-density lipoprotein-independent effects of statinsJ Davignon, R Laaksonen
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
The American Journal of Cardiology|June 27, 1986
Medical management of hyperlipidemia and the role of probucolJ Davignon
The Canadian Journal of Cardiology|June 17, 1998
Advances in drug treatment of dyslipidemia: focus on atorvastatinJ Davignon
International Journal of Clinical Practice. Supplement|July 23, 2005
Cardioprotective and other emerging effects of statinsJ Davignon
Progress in Clinical and Biological Research|January 1, 1979
Assessment of atherosclerosis for genetic analysis - emphasis on clinical expression or pathogenetic mechanism?J Davignon
L'Union Medicale Du Canada|December 1, 1976
[Plasma apolipoproteins]P Duclos, J Davignon
L'Union Medicale Du Canada|July 1, 1977
[Plasma apoproteins in dyslipoproteinemias. I. The hypolipidemias]P Duclos, J Davignon
L'Union Medicale Du Canada|July 1, 1978
[Plasma apolipoproteins in dyslipoproteinemias. III. LCAT deficiency and other hyperlipidemias]P Duclos, J Davignon
The American Journal of Cardiology|September 16, 1998
Current and future treatment of hyperlipidemia: the role of statinsM Farnier, J Davignon
L'Union Medicale Du Canada|November 1, 1971
[Combined electrophoresis and ultracentrifugation in diagnosis of primary hyperlipidemia]J Davignon, M Langelier
Current Opinion in Lipidology|February 19, 2000
Low-density lipoprotein-independent effects of statinsJ Davignon, R Laaksonen
Pageof 24